NICOLE DAISA: Open Payments
NPI 1861924516 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 39 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $177 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| Genentech USA, Inc. | 3 | $90 |
| Janssen Biotech, Inc. | 3 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| SOBI, INC | 2 | $52 |
| Exelixis Inc. | 1 | $45 |
| Invivyd Inc | 2 | $44 |
| Iovance Biotherapeutics, Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $32 |
Products named: KEYTRUDA, IMFINZI, TAGRISSO, ICLUSIG, CABOMETYX, RYBREVANT, ERLEADA, PEMGARDA.
Industry payments across CA — which companies pay providers there.
